New treatment with omalizumab may desensitize kids with milk allergies

New treatment may desensitize kids with milk allergies, say researchers at Stanford and Boston – Milk allergy is the most common, affecting 2.5 percent of children under age 3. In a small clinical study, researchers report effectively desensitizing milk-allergic patients by increasing their exposure to milk in tandem with an allergy drug called omalizumab, allowing children to build up resistance quickly with limited allergic reactions.

Do NOT follow this link or you will be banned from the site!